VitalConnect, Inc., a provider of wearable biosensor technology for wireless monitoring in hospital and remote patient populations has raised $38 million in Series C funding led by MVM and Baxter Ventures. This funding will help VitalConnect in launching the VitalConnect Platform and VitalPatch wearable biosensor in hospitals and outpatient settings across the nation.Founded in 2011, VitalConnect combines the most sophisticated biosensor - the VitalPatch - with its comprehensive software
Read More
VitalConnect Lands $33M to Commercialize Medical-Grade Wearable Biosensor Platform
VitalConnect, a San Jose, CA-based provider of medical-grade wearable biosensor systems has raised $33 million in Series C funding led by new investors MVM Life Science Partners and Baxter Ventures, the venture arm of Baxter International. The company plans to utilize the funding to commercialize the VitalConnect Platform and make significant strides in changing the way patient monitoring is utilized in hospitals and at home. As part of the latest funding round, Dr. Stephen Reeders, MVM founder,
Read More